KLDO News and Press, Kaleido Biosciences Inc. From 09/29/20

Kaleido Biosciences (KLDO) -1.2% in premarket has dosed the first patient in a clinical study evaluating KB295, a Microbiome Metabolic Therapy candidate, for the treatment of ulcerative colitis ((UC)), an inflammatory bowel disease characterized by long-lasting i...

LEXINGTON, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO) today announced that the first patient has been dosed in its clinical study evaluating Microbiome Metabolic Therapy (MMT™) candidate KB295 in patients with mild-to-moderate ulcerative coliti...

Gainers: Genfit (GNFT) +35%, Trxade Group (MEDS) +20%, Celldex Therapeutics (CLDX) +15%, EDAP TMS (EDAP) +13%, Kaleido Biosciences (KLDO) +8%.Losers: Abeona Therapeutics (ABEO) -33%, Aquestive Therapeutics (AQST) -35%, Mallinckrodt (MNK)&...

Gainers: Genfit (GNFT) +15%, Evogene (EVGN) +13%, Marinus Pharmaceuticals (MRNS) +11%, Endo International (ENDP) +8%, Happiness Biotech Group (HAPP) +7%.Losers: Rite Aid (RAD) -10%, Cellect Biotechnology (APOP) -8%, Kaleido...

Gainers: Sunworks (SUNW) +301%.The Peck Company (PECK) +172%.Just Energy (JE) +77%.Polar Power (POLA) +74%.Owens & Minor (OMI) +56%.Net Element (NETE) +41%.Kaleido Biosciences (KLDO) +38%.LogicBio Therapeutics (LOGC) +33%.Exact Sciences (EXAS) +24%.Pioneer Power Solutions (PPSI)...

Gainers: Owens & Minor OMI +53%, Kaleido Biosciences (KLDO) +39%, LogicBio Therapeutics (LOGC) +30%,  Cellect Biotechnology (APOP) +25%, Neuronetics (STIM) +6%.Losers: MediciNova MNOV -20%, Rite Aid RAD -17%, ADiTx Therapeut...

LEXINGTON, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), today announced that Michael Bonney, Executive Chair, will participate in the following upcoming conferences in September. Each conference will involve a fireside chat presentation. Event: Morg...

LEXINGTON, Mass., Aug. 27, 2020 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO) today announced that data from Microbiome Metabolic Therapy (MMT™) candidate KB174 for hepatic encephalopathy (HE) will be featured during The Digital International Liver Congress™...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

LEXINGTON, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to targeting the microbiome to treat disease and improve human health, today announced that Michael Bonney, Executive Chair, wil...